Texas | U.S.A.
| Investor Type | Firm |
| Type of Fund | Venture Capital Fund |
| Industries | BioTech • FinTech (& Financials services) • Energy • HealthTech (& Fitness) • Medical Devices (& Hospital Services) • Healthcare (& Wellness) |
| Stages | Seed, Series A, Series B |
| Investing | United States |
| Investment Range | $100,000 - $5,000,000 |
| Investment Sweet Spot | $1,500,000 |
About The Fund
Bios Partners is a venture capital firm headquartered in Fort Worth, Texas, with a focus on investing in innovative companies within the healthcare sector. They target sectors such as healthcare devices and supplies, biotech, fintech and financial services, energy, health tech and fitness, medical devices and hospital services, and healthcare and wellness. With an expertise in equity, they provide seed through Series B financing to startup companies, with investment amounts ranging from a minimum of $100,000 to a maximum of $5,000,000, and a sweet spot investment around $1,500,000. Bios Partners places a special emphasis on disruptive companies in overlooked and under-invested markets in the U.S., particularly in the Central U.S., to counteract the coastal concentration of venture capital. They believe that great science and investment opportunities are evenly distributed throughout the country and aim to unearth and nurture these opportunities to bring transformative healthcare solutions to market. Their portfolio includes advanced small molecules, medical devices, engineered cell therapy, digital medicines and AI, recombinant proteins and antibodies, and a range of other healthcare-related innovations. Bios Partners leverages their combined 80 years of experience in hedge funds, private equity, clinical drug development, and public pharma/biotech analysis to identify and grow their investments. They are devoted to company cultivation and are driven by strong foundational science to deliver significant value to the healthcare industry and their portfolio companies, bringing to market solutions such as novel therapeutics for high-impact cancers, cell therapies for cancer treatment, non-invasive devices for retinal degeneration, and AI-driven approaches for drug repurposing in oncology.
Contact over 100,000 investors!
Built by serial entrepreneurs and ex-VCs, Angels Partners helps entrepreneurs connect with relevant investors in their industry.
With over 100K+ listed investors, our mission is to help founders secure meetings & accelerate their fundraising.
View previous deals, filter by deal size, industry, location and more. It's the fastest way to build a target investor list.
e
We also built a community of hundreds of investors actively prospecting & investing directly on Angels Partners.
Register to become visible to a large community of investors on our platform.
- Prime Founders
- 85 Great Portland St.
- London, U.K.
- contact@angelspartners.com
